Are vitamin D receptor agonists like angiotensin-converting enzyme inhibitors without side effects?

Hess, 1992, The prevention and cure of rickets by sunlight, Am J Public Health (NY), 12, 104, 10.2105/AJPH.12.2.104 Agarwal, 2009, Vitamin D, proteinuria, diabetic nephropathy, and progression of CKD, Clin J Am Soc Nephrol, 4, 1523, 10.2215/CJN.02010309 Li, 2009, Renoprotective effects of vitamin D analogs Li, 2002, 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system, J Clin Invest, 110, 229, 10.1172/JCI0215219 Li, 2004, Vitamin D: a negative endocrine regulator of the renin-angiotensin system and blood pressure, J Steroid Biochem Mol Biol, 89–90, 387, 10.1016/j.jsbmb.2004.03.004 Zhang, 2008, Renoprotective role of the vitamin D receptor in diabetic nephropathy, Kidney Int, 73, 163, 10.1038/sj.ki.5002572 Deb, 2010, Combined vitamin D analog and AT1 receptor antagonist synergistically block the development of kidney disease in a model of type 2 diabetes, Kidney Int, 77, 1000, 10.1038/ki.2010.22 Zhang, 2008, Combination therapy with AT1 blocker and vitamin D analog markedly ameliorates diabetic nephropathy: blockade of compensatory renin increase, Proc Natl Acad Sci USA, 105, 15896, 10.1073/pnas.0803751105 Bodyak, 2007, Activated vitamin D attenuates left ventricular abnormalities induced by dietary sodium in Dahl salt-sensitive animals, Proc Natl Acad Sci USA, 104, 16810, 10.1073/pnas.0611202104 Agarwal, 2005, Antiproteinuric effect of oral paricalcitol in chronic kidney disease, Kidney Int, 68, 2823, 10.1111/j.1523-1755.2005.00755.x Agarwal, 2002, Dipstick proteinuria: can it guide hypertension management?, Am J Kidney Dis, 39, 1190, 10.1053/ajkd.2002.33389 Alborzi, 2008, Paricalcitol reduces albuminuria and inflammation in chronic kidney disease: a randomized double-blind pilot trial, Hypertension, 52, 249, 10.1161/HYPERTENSIONAHA.108.113159 Szeto, 2008, Oral calcitriol for the treatment of persistent proteinuria in immunoglobulin A nephropathy: an uncontrolled trial, Am J Kidney Dis, 51, 724, 10.1053/j.ajkd.2007.12.038 Fishbane, 2009, Oral paricalcitol in the treatment of patients with CKD and proteinuria: a randomized trial, Am J Kidney Dis, 54, 647, 10.1053/j.ajkd.2009.04.036 Lambers Heerspink, 2009, The Selective Vitamin D Receptor Activator for Albuminuria Lowering (VITAL) study: study design and baseline characteristics, Am J Nephrol, 30, 280, 10.1159/000225903